MAPK3 and hepatocellular carcinoma: TOP2A may promote hepatocellular carcinoma progression by facilitating epithelial‐mesenchymal transition mediated by the p‐ERK1/2/p‐SMAD2/Snail pathway, which has been associated with a poor prognosis in hepatocellular carcinoma.32